Su‐Peng Yeh
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 42
- Acute Myeloid Leukemia Research 24
- Multiple Myeloma Research and Treatments 12
- Hematopoietic Stem Cell Transplantation 10
- Chronic Myeloid Leukemia Treatments 5
- Genetics 24
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Co-authors
- Mien‐Chie Hung (5 shared papers)Long‐Yuan Li (7 shared papers)Cheng‐Chieh Yang (2 shared papers)Chun-Yi Lin (1 shared paper)Chien‐Chen Lai (1 shared paper)Jing‐Yu Lang (1 shared paper)Yongkun Wei (1 shared paper)Jer-Yen Yang (1 shared paper)
- Journals
- Blood (13 papers)Journal of Clinical Oncology (9 papers)Annals of Hematology (7 papers)PLoS ONE (3 papers)International Journal of Hematology (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Su‐Peng Yeh
90 papers receiving 1.9k citations
Su‐Peng Yeh's Hit Papers
Peers
Comparison fields: 5 of 109
- Hematology 623
- Genetics 231
- Cancer Research 289
- Molecular Biology 904
- Oncology 285
Countries citing papers authored by Su‐Peng Yeh
This map shows the geographic impact of Su‐Peng Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Peng Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Peng Yeh more than expected).
Fields of papers citing papers by Su‐Peng Yeh
This network shows the impact of papers produced by Su‐Peng Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Peng Yeh. The network helps show where Su‐Peng Yeh may publish in the future.
Co-authors
The 25 scholars most cited alongside Su‐Peng Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia Hit paper breakdown → | 2022 | 314 |
| 2 | 2010 | 311 | |
| 3 | 2021 | 105 | |
| 4 | 2013 | 86 | |
| 5 | 2017 | 61 | |
| 6 | 2016 | 56 | |
| 7 | 2011 | 53 | |
| 8 | 2011 | 51 | |
| 9 | 2018 | 48 | |
| 10 | 2016 | 43 | |
| 11 | 2017 | 43 | |
| 12 | 2021 | 41 | |
| 13 | 2019 | 36 | |
| 14 | 2022 | 36 | |
| 15 | 2013 | 34 | |
| 16 | 2012 | 34 | |
| 17 | 1998 | 29 | |
| 18 | 2011 | 27 | |
| 19 | 2013 | 25 | |
| 20 | 2011 | 24 |
About Su‐Peng Yeh
Su‐Peng Yeh is a scholar working on Hematology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 98 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (17 papers), Multiple Myeloma Research and Treatments (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Hematology (623 citations), Genetics (231 citations), Cancer Research (289 citations), Molecular Biology (904 citations) and Oncology (285 citations). Su‐Peng Yeh has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mien‐Chie Hung, Long‐Yuan Li, Cheng‐Chieh Yang, Chun-Yi Lin, Chien‐Chen Lai, Jing‐Yu Lang, Yongkun Wei, Jer-Yen Yang, Bin Shi and Andre C. Schuh. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, PLoS ONE and International Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.